PDF-Radiation Therapy for Hematologic Malignancies

Lymphoma Foundation Canada Richard Tsang MDRadiation OncologistPrincess Margaret Cancer CentreProfessor Dept Radiation OncologyUniversity of Toronto Role of Radiation Therapy LymphomaHodgkin Stage. Educational Objectives. Minimal Residual Disease. Flow Cytometry. MRD Sensitivity Using Flow Cytometry. By Disease State. Genetic Methods for MRD Quantification. Allele-Specific Oligonucleotide (ASO)-PCR. Bradley . Burton, . PharmD. , BCOP, . CACP. September 13, 2014. 1. Disclosure. No personal or financial disclosures to report. This continuing education activity contains discussion of published and/or investigational uses that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indication, contraindications, and warnings.. . Suzette Turner . Nurse Practitioner. Sunnybrook Health Sciences Centre. Amin . Zagzoog. C. ardiology Resident. University of Toronto. FACULTY/PRESENTER DISCLOSURE. Faculty. : Amin . Zagzoog. Radiation Therapy (R/T) For Cancer. About 99% of patients treated with Radiation Therapy (R/T) have malignancies. Approximately 60% of patients with cancer require Radiation Therapy. About 60% get R/T with the aim to cure. for EARLY-STAGE BREAST CANCER. Dr. Maria C.E. Jacobs. Director, Radiation Oncology. Mercy Medical Center. Baltimore, Maryland. EARLY-STAGE BREAST: . . Local Breast Treatment. BCT consisting of conservative surgery (CS) with lumpectomy/partial mastectomy and RT. Learning Goals. Immunotherapies in B-Cell Malignancies. Available Immunotherapies. OS in MM. Poor Outcome in High-Risk Myeloma. Immunotherapy. Potential for Success Without a Targetable Molecular Mutation. By. Dr. Amr A. . Abd-Elghany. Introduction to Radiation Oncology. Radiation has been an effective tool for treating cancer for more than 100 years. .. Radiation oncologists are doctors trained to use radiation to eradicate cancer. Scanning Proton . Beam . Therapy (. US PBT. ) versus . Intensity Modulated Radiation Therapy (IMRT. ). for . Mediastinal. Malignancies. . John . Han-. Chih. Chang, MD. 3. ,  . Shae. . Gans. , CMD. June 28, 2018. Management of hematologic malignancies in older patients. Disclosures. for Tanya Wildes. Honorarium. Carevive. Systems. Research Funding. Janssen. Key issues (1). Are the considerations in older adults with hematologic malignancies different than in solid tumors?. After receiving a request from the WTC Clinical Centers of Excellence to review certain myeloid disorders in terms of their status as malignancies, 1 the WTC Health Program has determined that, 2 e g The cell life cycle The cell cycle G0 = Cell is resting G1 = RNA and proteins are made S = DNA is made G2 = Apparatus for mitosis is built M = Mitosis (the cell divides into 2 cells) G0 phase (restin D. A. Low, , W. Lu, , C. A. Perez, MDDepartment of Radiation Oncology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, 4921 Parkview Place, St. Louis, MO 63110, USAJ. A. Jochrys. I. . Estanislao. , MD. Pediatric Hematologist-Oncologist. Epidemiology of Childhood and Adolescent Cancer. Top 3 Cancers in Children. Hematopoietic Cancers – 40%. Acute Lymphoblastic Leukemia. Georgette A. Dent, MD. University of North Carolina School of Medicine. Objectives. To review normal peripheral blood, bone marrow, and lymph node pathology. To briefly review the categories of treatment used to treat these malignancies.